Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes

Jens Hohwü Voigt, Katrine M. Lauritsen, Steen Bønløkke Pedersen, Troels K. Hansen, Niels Møller, Niels Jessen, Marcello C. Laurenti, Chiara Dalla Man, Adrian Vella, Lars C. Gormsen, Esben Søndergaard

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds